$Inflammatory bowel disease and the risk of fracture.$

Inflammatory bowel disease and the risk of fracture.

Show other versions (3)

BACKGROUND and AIMS: Although patients with inflammatory bowel disease (IBD) have reduced bone mass, there is controversy whether there is an increased risk of fracture. This study examines the risk of fracture and its predictors in patients with IBD. METHODS: In a primary care- based nested case-c...

书目详细资料
Main Authors:	van Staa, T, Cooper, C, Brusse, L, Leufkens, H, Javaid, M, Arden, N
格式:	Journal article
语言:	English
出版:	2003

相似书籍

INFLAMMATORY BOWEL DISEASE AND THE RISK OF FRACTURE
由: Arden, N, et al.
出版: (2003)

Inflammatory bowel disease and the risk of fracture
由: van Staa, T, et al.
出版: (2002)

Inflammatory bowel disease and the risk of fracture
由: van Staa, T, et al.
出版: (2003)

Use of nonsteroidal anti-inflammatory drugs and risk of fractures.
由: van Staa, T, et al.
出版: (2000)

Inhaled corticosteroids and risk of fractures
由: Van Staa, T, et al.
出版: (2000)

Use of inhaled corticosteroids and risk of fractures.
由: van Staa, T, et al.
出版: (2001)

Inhaled corticosteroids and hip fracture: disease or drugs?
由: van Staa, T, et al.
出版: (2003)

Children and the risk of fractures caused by oral corticosteroids.
由: van Staa, T, et al.
出版: (2003)

Diseases and drugs associated with osteoporosis predict fractures at different sites
由: van Staa, T, et al.
出版: (2001)

Are inhaled corticosteroids associated with an increased risk of fracture in children?
由: van Staa, T, et al.
出版: (2004)

Utility of medical and drug history in fracture risk prediction among men and women.
由: van Staa, T, et al.
出版: (2002)

The use of inhaled corticosteroids is not associated with an increased risk of fracture in children.
由: van Staa, T, et al.
出版: (2001)

Osteoporosis in patients with inflammatory bowel disease.
由: Arden, N, et al.
出版: (2002)

Use of oral corticosteroids and risk of fractures.
由: Van Staa, T, et al.
出版: (2000)

Use of statins and risk of fractures.
由: van Staa, T, et al.
出版: (2000)

Does a fracture at one site predict later fractures at any other site?
由: van Staa, T, et al.
出版: (2001)

Disease severity of asthma/copd and risk of osteoporotic fractures
由: de Vries, F, et al.
出版: (2005)

Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
由: de Vries, F, et al.
出版: (2007)

Does a fracture at one site predict later fractures at other sites? A British cohort study.
由: van Staa, T, et al.
出版: (2002)

Use of oral corticosteroids and risk of fractures. June, 2000.
由: Van Staa, T, et al.
出版: (2005)

Severity of obstructive airway disease and risk of osteoporotic fracture.
由: de Vries, F, et al.
出版: (2005)

Use of statins and risk of fractures.
由: van Staa, T, et al.
出版: (2001)

Statins and fracture risk - Reply
由: van Staa, T, et al.
出版: (2001)

Oral corticosteroids and fracture risk: relationship to daily and cumulative doses.
由: van Staa, T, et al.
出版: (2000)

Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?
由: Bazelier, M, et al.
出版: (2012)

Use of Thiazolidinediones and Risk of Osteoporotic Fracture: Disease or Drugs?
由: Bazelier, M, et al.
出版: (2011)

USE OF THIAZOLIDINEDIONES AND RISK OF OSTEOPOROTIC FRACTURE: DISEASE OR DRUGS?
由: Bazelier, M, et al.
出版: (2010)

Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.
由: van Staa, T, et al.
出版: (2006)

Epidemiology of fractures in England and Wales.
由: van Staa, T, et al.
出版: (2001)

The epidemiology of fractures in England and Wales
由: van Staa, T, et al.
出版: (2001)

KNEE ARTHOPLASTY AND RISK OF HIP FRACTURE: A POPULATION-BASED CASE-CONTROL STUDY
由: Lalmohamed, A, et al.
出版: (2010)

Use of statins, risk of fracture and age-band bias
由: De Vries, F, et al.
出版: (2006)

CUMULATIVE RISKS OF FRACTURE IN PATIENTS USING ORAL GLUCOCORTICOIDS
由: Van Staa, T, et al.
出版: (2004)

The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results.
由: Van Staa, T, et al.
出版: (2000)

Use of oral corticosteroids and risk of fractures (reprinted from JBMR, vol. 15, pg. 993-1000, yr. 2000)
由: Van Staa, T, et al.
出版: (2005)

Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands.
由: de Vries, F, et al.
出版: (2007)

Fracture risk with intermittent high-dose oral glucocorticoid therapy.
由: De Vries, F, et al.
出版: (2007)

Body mass index and bone mineral density by dexa in inflammatory bowel disease
由: Stroud, M, et al.
出版: (2001)

Use of beta-blockers and risk of hip and vertebral fracture: relationships to daily and cumulative dose
由: De Vries, F, et al.
出版: (2006)

Use of beta-2 agonists and risk of hip fracture
由: De Vries, F, et al.
出版: (2006)